Nanoveu

30/04/2022

We are pleased to provide an overview of activities to accompany the Appendix 4C for the quarter ended 31 March 2022

Read announcement: https://buff.ly/3vsV2ld

$NVU

06/04/2022

We are pleased to announce that the Company’s NanoshieldTM Antiviral Liquid Spray has been listed by the Singapore National Environmental Agency as a Self-Disinfecting Surface Coating Products Effective Against Coronaviruses

Read: https://buff.ly/3KlItxo

$NVU

28/03/2022

We are pleased to provide shareholders and investors with a recording from the recent Broker Briefing Technology and Biotechnology Investor Webinar where Non-executive Chairman, Scott Beeton, advised on the Company's latest activities.

📽️ Watch https://buff.ly/3DkceM7

$NVU

For the Broker Briefing March 2021 Tech & Biotech Investor Webinar, Nanoveu (ASX:NVU) Non-Executive Chairman, Scott Beeton, provides an overview on their range of NanoshieldTM antimicrobial and antiviral solutions and discusses the company growth strategy for 2022.

23/03/2022

Join Non-executive Chairman, Scott Beeton, at the free Broker Briefing Tech & Biotech Investor Webinar.

📆 TODAY - Thursday, 24 March 2022
⌚️ 11:30am AEDT / 8:30am AWST
📌 Register - https://buff.ly/3N9klQ4

$NVU

$NVU

22/03/2022

Join Non-executive Chairman, Scott Beeton, at the free Tech & Biotech Investor Webinar.

📆 Thursday, 24 March 2022
⌚️ 11:30am AEDT / 8:30am AWST
📌 Register - https://buff.ly/3N9klQ4

$NVU

18/03/2022

$NVU - Nanoveu announces its launch of the Nanoshield Bot, the world’s first disinfection bot which kills viruses and bacteria, including COVID-19

Article by
https://buff.ly/3whlhfi

$NVU

Nanoveu Limited (ASX:NVU) announced its launch of the Nanoshield Bot, the world's first disinfection bot which kills viruses and bacteria, including SARS-CoV-2 (COVID-19) using their new e-water formulation that is alcohol-free and Halal-certified.

09/03/2022

We are pleased to announce that the Company has received approval for the registration of its NanoshieldTM Film line as a Class I medical device with the UK-based Medicines and Healthcare products Regulatory Agency for the UKCA Mark

https://buff.ly/3tGRObP

$NVU

08/03/2022

We are pleased to announce that the Company has applied for registration of its NanoshieldTM Film line as a Class I medical device with the UK-based Medicines and Healthcare products Regulatory Agency (MHRA) for the UKCA (UK Conformity Assessed) Mark. The NanoshieldTM product, which is a protective film employing a transparent resin with activated copper exhibiting antimicrobial and antiviral properties, will now be able to be marketed for a range of medical and non-medical applications in the United Kingdom.

Commenting on the submission Nanoveu’s Managing Director and CEO, Alfred Chong, said: “Nanoveu continues to support its Nanoshield product in a range of international markets and is exceptionally pleased that it has been filed for registration as a Class I medical device in the UK. This is important as it enhances the reach of our products, but also builds confidence amongst end users that Nanoshield is accepted in major markets such as the UK. The registration quickly follows similarly positive regulatory news with the product receiving EPA Approval in the USA.

“By any measure, the UK is one of the largest healthcare markets, with the UK’s National Health Service being one of the world’s largest employers, and the nation is also home to a number of other major health organisations. Given its global significance, the UK is an important target for Nanoveu.

“Nanoveu will continue to make regulatory submissions to key medical markets across the globe and will endeavour to keep shareholders updated as further progress is made.”

Read Announcement: https://buff.ly/3ITTwgv

$NVU

09/02/2022

We are pleased to announce the launch of ‘Liquid Film’, a spray-on version of the Company’s antibacterial and antiviral surface protection films, with the product achieving a >99.99% reduction of MHV within 10 minutes.

➡️ https://buff.ly/3gzWHgA

02/12/2021

How Nanoveu’s innovative disinfectant tech will combat Omicron

“The current pandemic has taught us many things but the most important of which is a reminder that no matter how much we want our lives to return to normalcy, a single mutation can set us backwards,” Nanoveu founder and CEO Alfred Chong told Stockhead.

“On that note, we should always be on the defensive, taking the extra steps to ensure we remain safe. In developing our product, we looked at certain attributes which are now showing its resilience.

“The patented antiviral agent we have deployed for our products is not only grounded in science, but has been time tested by leading laboratories globally, customer-validated by tier 1 multinational companies, and has the potential to significantly contribute to the global fight against the virus for years to come.”

📚 Article by Stockhead ➡️ https://buff.ly/31fKwkN

$NVU

The recent emergence of the Omicron coronavirus variant serves as a reminder that the world needs to continue doing its level best to combat the illness.

24/11/2021

We are pleased to provide Investors and Shareholders with a recording from the recent Broker Briefing Investor Webinar

📽️ Watch ➡️ https://buff.ly/2ZdsiQm

$NVU

18/11/2021

Nanotechnology company Nanoveu receives patent cooperation treaty approval for EyeFyx

📚 Article by The Market Herald ➡️ https://buff.ly/2YZEuUz

$NVU

Nanotechnology company Nanoveu (ASX:NVU) has received patent cooperation treaty approval for EyeFyx.

18/11/2021

We are pleased to provide Shareholders and Investors with an updated Investor Presentation.

📚 Download presentation ➡️ https://buff.ly/3oAObSl

$NVU

16/11/2021

We are pleased to provide shareholders and investors with a recording from the recent Investor Webinar.

📽️ Watch

$NVU

Jane Morgan Management is a boutique Investor Relations & Media Communications consultancy group providing services to ASX listed clients.Combining over 15 y...

14/11/2021

We are pleased to advise shareholders and investors that the Company will be presenting as part of the free Broker Briefing Investor Webinar

📆 18 November 2021
⌚️ 11:30am AEDT / 8:30am AWST
📌 Register via - https://buff.ly/30q1a0N

10/11/2021

We are pleased to provide Investors and Shareholders with an updated Investor Presentation.

📚 Read ➡️ https://buff.ly/3kmZufy

$NVU

29/10/2021

We are pleased to provide an overview of activities to accompany the Appendix 4C for the quarter ended 30 September 2021.

📚 ➡️https://buff.ly/3vWKMR5

$NVU

06/05/2021

The Terang Co-op has introduced new virus protection measures that will provide long-term health and safety benefits to customers.
The Co-op has added Touch Guard’s Nanoveu’s antiviral protective shields to its shopping trolleys and door handles.
It is believed the Co-op is the first major retailer in the region to introduce this safety measure.

Terang Co-op CEO Kevin Ford said the protective shields would become a permanent part of the Co-op’s shopping experience, even after COVID-19.
“These handle covers give protection against viruses and bacteria, even if the handles are exposed to sun and rain,” Mr Ford said.
“We expect to keep them after COVID-19. Given the lessons we have learned during the pandemic, if we can reduce the risk of spreading even the common cold it’s better off for all of us.”
The covers only need to be wiped once a day with a soft cloth. They will be replaced after six months.
The contractor doing new signage for the redevelopment of the Co-op’s Mitre 10, Rural Store and Supa IGA is also an installer of the Touchguard product.
“We learnt about this option from the contractor and thought it would be a good investment for community safety,” Mr Ford said. “I’m not aware of any other major retailers in the area doing this,” he added.
The total handle of the supermarket trolley is protected and areas on fridge doors near the touch Guard label will be protected.
Mr Ford said the Nanoveu antiviral technology had been independently demonstrated to be highly effective in eradicating viruses.
The technology has been proven to eliminate 99.99% of OC43, a viral strain affecting humans that is also a surrogate for COVID-19, in 30 minutes.
This antiviral protection has also been validated against other bacteria and viruses, including e. Coli, Influenza A (subtype H3N2), and coronavirus MHV-A592.
The move comes as staff and customers are no longer required to wear masks in the supermarket.
“People have been fantastic with wearing masks,” Mr Ford said. “To be able to go into a number of businesses and not be required to wear a mask and then manage to maintain the rules in supermarkets has been very impressive.” The Co-op has provided disposable masks to those who forget.
In another initiative, the Co-op has introduced new weekly member specials in the IGA store.
“We are running about 50 different weekly specials with low prices solely for Co-op members,” Mr Ford said.
He said the initiative in the IGA supermarket followed compliments about the recent store refurbishment and as a reward for members.